Source link : https://newshealth.biz/health-news/monthly-glp-1-for-obesity-promising-as-more-manageable-alternative/
NEW ORLEANS — Injections of an ultra-long-acting investigational GLP-1 agonist led to significant weight loss in people with overweight or obesity, with reductions continuing after a switch to once-monthly dosing, according to the ongoing VESPER clinical program. After an initial 12-week titration period with weekly dosing, average body weight with the 4.8-mg monthly dose level […]
The post Monthly GLP-1 for Obesity Promising as More Manageable Alternative first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-08 17:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8